prasugrel 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| platelet aggregation inhibitors | 4113 | 150322-43-3 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNSTABLE ANGINA and MYOCARDIAL INFARCTION, as well as in those undergoing PERCUTANEOUS CORONARY INTERVENTIONS.
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 10 | mg | O |
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| BDDCS (Biopharmaceutical Drug Disposition Classification System) | 2 | Benet LZ, Broccatelli F, Oprea TI |
| EoM (Fraction excreted unchanged in urine) | 1 % | Benet LZ, Broccatelli F, Oprea TI |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Feb. 24, 2009 | EMA | DAIICHI SANKYO EUROPE GMBH | |
| July 10, 2009 | FDA | ELI LILLY AND CO | |
| March 24, 2014 | PMDA | DAIICHI SANKYO COMPANY, LIMITED |
FDA Adverse Event Reporting System (Female)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Myocardial infarction | 163.20 | 20.90 | 94 | 4101 | 99799 | 63385028 |
| Thrombosis in device | 136.23 | 20.90 | 33 | 4162 | 2957 | 63481870 |
| Acute myocardial infarction | 113.55 | 20.90 | 51 | 4144 | 32073 | 63452754 |
| Vascular pseudoaneurysm | 107.38 | 20.90 | 24 | 4171 | 1510 | 63483317 |
| Vascular stent stenosis | 93.67 | 20.90 | 18 | 4177 | 535 | 63484292 |
| Gastrointestinal haemorrhage | 81.03 | 20.90 | 56 | 4139 | 81120 | 63403707 |
| Coronary artery restenosis | 68.15 | 20.90 | 13 | 4182 | 371 | 63484456 |
| Haemorrhage | 62.99 | 20.90 | 43 | 4152 | 60979 | 63423848 |
| Coronary artery occlusion | 60.11 | 20.90 | 22 | 4173 | 8169 | 63476658 |
| Angina pectoris | 59.02 | 20.90 | 32 | 4163 | 30046 | 63454781 |
| Coronary artery disease | 54.12 | 20.90 | 31 | 4164 | 32346 | 63452481 |
| Angina unstable | 51.85 | 20.90 | 19 | 4176 | 7076 | 63477751 |
| Chest pain | 42.15 | 20.90 | 61 | 4134 | 215898 | 63268929 |
| Cerebrovascular arteriovenous malformation | 41.70 | 20.90 | 7 | 4188 | 94 | 63484733 |
| Haematoma | 37.00 | 20.90 | 25 | 4170 | 34795 | 63450032 |
| Coronary artery stenosis | 35.76 | 20.90 | 13 | 4182 | 4731 | 63480096 |
| Phaeochromocytoma crisis | 35.28 | 20.90 | 7 | 4188 | 246 | 63484581 |
| Platelet function test abnormal | 35.25 | 20.90 | 6 | 4189 | 88 | 63484739 |
| Retroperitoneal haemorrhage | 34.15 | 20.90 | 11 | 4184 | 2786 | 63482041 |
| Aneurysm | 34.01 | 20.90 | 11 | 4184 | 2822 | 63482005 |
| Stent placement | 30.97 | 20.90 | 11 | 4184 | 3744 | 63481083 |
| Somnambulism | 30.26 | 20.90 | 12 | 4183 | 5531 | 63479296 |
| Device occlusion | 30.18 | 20.90 | 13 | 4182 | 7374 | 63477453 |
| Cerebral haemorrhage | 30.14 | 20.90 | 21 | 4174 | 30708 | 63454119 |
| Peripheral arterial occlusive disease | 29.77 | 20.90 | 11 | 4184 | 4190 | 63480637 |
| Acute coronary syndrome | 29.26 | 20.90 | 14 | 4181 | 10112 | 63474715 |
| Puncture site haemorrhage | 28.24 | 20.90 | 6 | 4189 | 297 | 63484530 |
| Myopathy | 27.93 | 20.90 | 14 | 4181 | 11177 | 63473650 |
| Epistaxis | 26.22 | 20.90 | 28 | 4167 | 72697 | 63412130 |
| Factor V inhibition | 25.33 | 20.90 | 5 | 4190 | 171 | 63484656 |
| Coronary artery thrombosis | 24.81 | 20.90 | 7 | 4188 | 1132 | 63483695 |
| Cardiogenic shock | 24.28 | 20.90 | 15 | 4180 | 17917 | 63466910 |
| Labelled drug-drug interaction medication error | 22.83 | 20.90 | 13 | 4182 | 13386 | 63471441 |
| Tachycardia paroxysmal | 22.54 | 20.90 | 5 | 4190 | 303 | 63484524 |
| Coronary arterial stent insertion | 22.25 | 20.90 | 8 | 4187 | 2821 | 63482006 |
| Coagulation factor V level decreased | 22.23 | 20.90 | 5 | 4190 | 323 | 63484504 |
| Subarachnoid haemorrhage | 22.06 | 20.90 | 13 | 4182 | 14270 | 63470557 |
| Photopsia | 21.98 | 20.90 | 9 | 4186 | 4500 | 63480327 |
| Thrombosis | 21.71 | 20.90 | 24 | 4171 | 64731 | 63420096 |
| Vascular stent thrombosis | 21.26 | 20.90 | 6 | 4189 | 971 | 63483856 |
| Ocular retrobulbar haemorrhage | 21.04 | 20.90 | 4 | 4191 | 112 | 63484715 |
FDA Adverse Event Reporting System (Male)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Thrombosis in device | 349.29 | 17.74 | 91 | 7592 | 3234 | 34946014 |
| Vascular stent thrombosis | 292.26 | 17.74 | 77 | 7606 | 2858 | 34946390 |
| Vascular stent stenosis | 202.97 | 17.74 | 48 | 7635 | 1133 | 34948115 |
| Acute myocardial infarction | 173.17 | 17.74 | 121 | 7562 | 53598 | 34895650 |
| Myocardial infarction | 154.79 | 17.74 | 160 | 7523 | 120925 | 34828323 |
| Chest pain | 116.34 | 17.74 | 141 | 7542 | 126621 | 34822627 |
| Angina pectoris | 108.83 | 17.74 | 74 | 7609 | 31289 | 34917959 |
| Coronary artery restenosis | 83.46 | 17.74 | 23 | 7660 | 1011 | 34948237 |
| Haemorrhage | 72.93 | 17.74 | 72 | 7611 | 51298 | 34897950 |
| Angina unstable | 72.59 | 17.74 | 40 | 7643 | 11613 | 34937635 |
| Gastrointestinal haemorrhage | 66.13 | 17.74 | 89 | 7594 | 88388 | 34860860 |
| Haemorrhage intracranial | 63.44 | 17.74 | 41 | 7642 | 15905 | 34933343 |
| Cardiac tamponade | 62.41 | 17.74 | 28 | 7655 | 5238 | 34944010 |
| Coronary artery stenosis | 59.87 | 17.74 | 33 | 7650 | 9583 | 34939665 |
| Labelled drug-drug interaction medication error | 58.41 | 17.74 | 38 | 7645 | 14901 | 34934347 |
| Vascular pseudoaneurysm | 44.27 | 17.74 | 17 | 7666 | 2150 | 34947098 |
| Haematoma | 42.20 | 17.74 | 39 | 7644 | 25566 | 34923682 |
| Coronary artery thrombosis | 40.78 | 17.74 | 16 | 7667 | 2143 | 34947105 |
| Coronary artery occlusion | 40.69 | 17.74 | 27 | 7656 | 10935 | 34938313 |
| Pericardial haemorrhage | 38.08 | 17.74 | 17 | 7666 | 3141 | 34946107 |
| Device occlusion | 34.10 | 17.74 | 20 | 7663 | 6525 | 34942723 |
| Pulmonary alveolar haemorrhage | 34.08 | 17.74 | 21 | 7662 | 7491 | 34941757 |
| Cerebral haemorrhage | 33.76 | 17.74 | 40 | 7643 | 34897 | 34914351 |
| Myocardial ischaemia | 33.61 | 17.74 | 29 | 7654 | 17379 | 34931869 |
| Intraventricular haemorrhage | 33.21 | 17.74 | 16 | 7667 | 3515 | 34945733 |
| Upper gastrointestinal haemorrhage | 32.93 | 17.74 | 34 | 7649 | 25484 | 34923764 |
| Apnoeic attack | 32.19 | 17.74 | 9 | 7674 | 417 | 34948831 |
| Coronary artery disease | 30.68 | 17.74 | 45 | 7638 | 48260 | 34900988 |
| Abdominal symptom | 30.06 | 17.74 | 9 | 7674 | 532 | 34948716 |
| Epistaxis | 29.65 | 17.74 | 49 | 7634 | 58202 | 34891046 |
| Subdural haematoma | 29.64 | 17.74 | 29 | 7654 | 20392 | 34928856 |
| Acute coronary syndrome | 29.10 | 17.74 | 24 | 7659 | 13521 | 34935727 |
| Obstructive shock | 26.25 | 17.74 | 5 | 7678 | 39 | 34949209 |
| Cardiac failure | 24.82 | 17.74 | 59 | 7624 | 91189 | 34858059 |
| Arterial restenosis | 23.53 | 17.74 | 5 | 7678 | 71 | 34949177 |
| Arterial injury | 23.19 | 17.74 | 7 | 7676 | 426 | 34948822 |
| Melaena | 22.52 | 17.74 | 33 | 7650 | 35347 | 34913901 |
| Platelet function test abnormal | 20.93 | 17.74 | 5 | 7678 | 123 | 34949125 |
| Toxicity to various agents | 20.83 | 17.74 | 9 | 7674 | 200353 | 34748895 |
| Peripheral arterial occlusive disease | 20.67 | 17.74 | 14 | 7669 | 5860 | 34943388 |
| Coombs negative haemolytic anaemia | 19.79 | 17.74 | 5 | 7678 | 156 | 34949092 |
| Procedural haemorrhage | 19.73 | 17.74 | 10 | 7673 | 2447 | 34946801 |
| Thrombotic cerebral infarction | 19.73 | 17.74 | 6 | 7677 | 374 | 34948874 |
| Non-cardiac chest pain | 19.46 | 17.74 | 12 | 7671 | 4285 | 34944963 |
| Thrombotic thrombocytopenic purpura | 19.43 | 17.74 | 11 | 7672 | 3359 | 34945889 |
| Vessel puncture site haematoma | 19.22 | 17.74 | 4 | 7679 | 51 | 34949197 |
| Coronary artery perforation | 18.81 | 17.74 | 4 | 7679 | 57 | 34949191 |
| Melanaemia | 18.38 | 17.74 | 4 | 7679 | 64 | 34949184 |
| Febrile neutropenia | 18.05 | 17.74 | 4 | 7679 | 136845 | 34812403 |
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Vascular stent thrombosis | 328.52 | 16.09 | 79 | 9782 | 3631 | 79730896 |
| Thrombosis in device | 270.06 | 16.09 | 73 | 9788 | 5369 | 79729158 |
| Acute myocardial infarction | 238.59 | 16.09 | 137 | 9724 | 76899 | 79657628 |
| Myocardial infarction | 233.04 | 16.09 | 188 | 9673 | 183941 | 79550586 |
| Gastrointestinal haemorrhage | 124.68 | 16.09 | 120 | 9741 | 147599 | 79586928 |
| Vascular stent stenosis | 122.28 | 16.09 | 30 | 9831 | 1497 | 79733030 |
| Vascular pseudoaneurysm | 114.77 | 16.09 | 34 | 9827 | 3476 | 79731051 |
| Haemorrhage | 106.51 | 16.09 | 89 | 9772 | 91029 | 79643498 |
| Coronary artery stenosis | 95.08 | 16.09 | 41 | 9820 | 12443 | 79722084 |
| Chest pain | 94.15 | 16.09 | 143 | 9718 | 282161 | 79452366 |
| Angina pectoris | 92.28 | 16.09 | 65 | 9796 | 51667 | 79682860 |
| Labelled drug-drug interaction medication error | 77.08 | 16.09 | 46 | 9815 | 27604 | 79706923 |
| Coronary artery occlusion | 71.97 | 16.09 | 36 | 9825 | 15279 | 79719248 |
| Coronary artery restenosis | 71.44 | 16.09 | 19 | 9842 | 1310 | 79733217 |
| Coronary artery disease | 68.41 | 16.09 | 60 | 9801 | 65414 | 79669113 |
| Haematoma | 67.28 | 16.09 | 54 | 9807 | 52141 | 79682386 |
| Haemorrhage intracranial | 66.38 | 16.09 | 41 | 9820 | 26152 | 79708375 |
| Angina unstable | 60.89 | 16.09 | 33 | 9828 | 16494 | 79718033 |
| Intraventricular haemorrhage | 57.71 | 16.09 | 22 | 9839 | 4865 | 79729662 |
| Cerebral haemorrhage | 54.60 | 16.09 | 50 | 9811 | 57623 | 79676904 |
| Coronary artery thrombosis | 51.65 | 16.09 | 18 | 9843 | 3088 | 79731439 |
| Acute coronary syndrome | 50.82 | 16.09 | 32 | 9829 | 21101 | 79713426 |
| Device occlusion | 50.24 | 16.09 | 26 | 9835 | 11840 | 79722687 |
| Epistaxis | 46.62 | 16.09 | 63 | 9798 | 111452 | 79623075 |
| Upper gastrointestinal haemorrhage | 45.38 | 16.09 | 39 | 9822 | 41341 | 79693186 |
| Pulmonary alveolar haemorrhage | 45.36 | 16.09 | 24 | 9837 | 11433 | 79723094 |
| Peripheral arterial occlusive disease | 43.54 | 16.09 | 21 | 9840 | 8237 | 79726290 |
| Cardiac tamponade | 41.22 | 16.09 | 21 | 9840 | 9255 | 79725272 |
| Subdural haematoma | 39.39 | 16.09 | 32 | 9829 | 31402 | 79703125 |
| Platelet function test abnormal | 38.30 | 16.09 | 8 | 9853 | 191 | 79734336 |
| Stent placement | 35.65 | 16.09 | 17 | 9844 | 6503 | 79728024 |
| Cerebrovascular arteriovenous malformation | 35.61 | 16.09 | 7 | 9854 | 122 | 79734405 |
| Cardiac failure | 33.70 | 16.09 | 65 | 9796 | 154777 | 79579750 |
| Pericardial haemorrhage | 31.73 | 16.09 | 14 | 9847 | 4481 | 79730046 |
| Thrombotic cerebral infarction | 29.90 | 16.09 | 8 | 9853 | 564 | 79733963 |
| Cardiogenic shock | 29.66 | 16.09 | 31 | 9830 | 41883 | 79692644 |
| Melaena | 29.48 | 16.09 | 37 | 9824 | 60853 | 79673674 |
| Phaeochromocytoma crisis | 28.91 | 16.09 | 7 | 9854 | 330 | 79734197 |
| Apnoeic attack | 28.60 | 16.09 | 8 | 9853 | 666 | 79733861 |
| Arterial injury | 27.90 | 16.09 | 8 | 9853 | 728 | 79733799 |
| Myocardial ischaemia | 27.87 | 16.09 | 24 | 9837 | 25495 | 79709032 |
| Abdominal symptom | 27.52 | 16.09 | 8 | 9853 | 765 | 79733762 |
| Cerebral infarction | 27.46 | 16.09 | 31 | 9830 | 45645 | 79688882 |
| Thrombosis | 27.08 | 16.09 | 42 | 9819 | 84058 | 79650469 |
| Subarachnoid haemorrhage | 26.70 | 16.09 | 23 | 9838 | 24442 | 79710085 |
| Electrocardiogram ST segment elevation | 26.10 | 16.09 | 15 | 9846 | 8382 | 79726145 |
| Somnambulism | 25.56 | 16.09 | 13 | 9848 | 5708 | 79728819 |
| Obstructive shock | 25.18 | 16.09 | 5 | 9856 | 92 | 79734435 |
| Aneurysm | 24.88 | 16.09 | 11 | 9850 | 3537 | 79730990 |
| Post procedural haemorrhage | 23.86 | 16.09 | 17 | 9844 | 13727 | 79720800 |
| Factor V inhibition | 23.13 | 16.09 | 6 | 9855 | 375 | 79734152 |
| Haematuria | 21.63 | 16.09 | 34 | 9827 | 68802 | 79665725 |
| Melanaemia | 20.61 | 16.09 | 4 | 9857 | 65 | 79734462 |
| Vascular stent occlusion | 20.58 | 16.09 | 5 | 9856 | 239 | 79734288 |
| Hypocalcaemia | 20.53 | 16.09 | 28 | 9833 | 49896 | 79684631 |
| Bladder tamponade | 20.51 | 16.09 | 6 | 9855 | 586 | 79733941 |
| Retroperitoneal haemorrhage | 20.36 | 16.09 | 11 | 9850 | 5459 | 79729068 |
| Hypomagnesaemia | 20.35 | 16.09 | 27 | 9834 | 46884 | 79687643 |
| Shock haemorrhagic | 20.17 | 16.09 | 18 | 9843 | 20042 | 79714485 |
| Ventricle rupture | 19.05 | 16.09 | 4 | 9857 | 98 | 79734429 |
| Alopecia | 18.88 | 16.09 | 3 | 9858 | 231352 | 79503175 |
| Infusion related reaction | 18.75 | 16.09 | 3 | 9858 | 230234 | 79504293 |
| Coombs negative haemolytic anaemia | 18.31 | 16.09 | 5 | 9856 | 381 | 79734146 |
| Tachycardia paroxysmal | 18.12 | 16.09 | 5 | 9856 | 396 | 79734131 |
| Product administration error | 18.10 | 16.09 | 21 | 9840 | 31825 | 79702702 |
| Retroperitoneal haematoma | 17.92 | 16.09 | 10 | 9851 | 5287 | 79729240 |
| Myopathy | 17.85 | 16.09 | 17 | 9844 | 20546 | 79713981 |
| Blood loss anaemia | 17.79 | 16.09 | 15 | 9846 | 15483 | 79719044 |
| Hepatitis acute | 17.75 | 16.09 | 15 | 9846 | 15527 | 79719000 |
| Pain | 17.66 | 16.09 | 38 | 9823 | 703764 | 79030763 |
| Ocular retrobulbar haemorrhage | 17.21 | 16.09 | 4 | 9857 | 158 | 79734369 |
| Trunk injury | 17.09 | 16.09 | 3 | 9858 | 27 | 79734500 |
| Coronary artery reocclusion | 17.04 | 16.09 | 4 | 9857 | 165 | 79734362 |
| Febrile neutropenia | 16.73 | 16.09 | 4 | 9857 | 230995 | 79503532 |
| Coronary arterial stent insertion | 16.69 | 16.09 | 10 | 9851 | 6034 | 79728493 |
| Ventricular fibrillation | 16.41 | 16.09 | 20 | 9841 | 31906 | 79702621 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | B01AC22 | BLOOD AND BLOOD FORMING ORGANS ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS Platelet aggregation inhibitors excl. heparin |
| FDA PE | N0000008832 | Decreased Platelet Aggregation |
| MeSH PA | D006401 | Hematologic Agents |
| MeSH PA | D010975 | Platelet Aggregation Inhibitors |
| FDA EPC | N0000182142 | P2Y12 Platelet Inhibitor |
| FDA MoA | N0000182143 | P2Y12 Receptor Antagonists |
| CHEBI has role | CHEBI:35554 | cardiovascular agent |
| CHEBI has role | CHEBI:50433 | platelet glycoprotein-IIb/IIIa receptor antagonists |
| CHEBI has role | CHEBI:68563 | ADP receptor subtype P2Y12 antagonists |
| CHEBI has role | CHEBI:50266 | Prodrugs |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Prevention of recurrence of ischemic cerebrovascular disease | indication | 62914000 | DOID:6713 |
| Acute coronary syndrome | indication | 394659003 | |
| Percutaneous coronary intervention | indication | 415070008 | |
| Myocardial Reinfarction Prevention | indication | ||
| Intracranial hemorrhage | contraindication | 1386000 | |
| Acute hemorrhage | contraindication | 8573003 | |
| Acute peptic ulcer with hemorrhage | contraindication | 12274003 | |
| Low blood pressure | contraindication | 45007003 | |
| Hepatic failure | contraindication | 59927004 | |
| Blood coagulation disorder | contraindication | 64779008 | DOID:1247 |
| Aortocoronary artery bypass graft | contraindication | 67166004 | |
| Thrombotic thrombocytopenic purpura | contraindication | 78129009 | DOID:10772 |
| Cerebrovascular accident | contraindication | 230690007 | |
| Transient ischemic attack | contraindication | 266257000 | DOID:224 |
| Surgical procedure | contraindication | 387713003 | |
| Traumatic injury | contraindication | 417746004 | |
| Significant Bleeding | contraindication |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 5.53 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| P2Y purinoceptor 12 | GPCR | ANTAGONIST | UNKNOWN | CHEMBL |
External reference:
| ID | Source |
|---|---|
| 4029056 | VUID |
| N0000179815 | NUI |
| D05597 | KEGG_DRUG |
| 389574-19-0 | SECONDARY_CAS_RN |
| 4029056 | VANDF |
| 4029068 | VANDF |
| C2683417 | UMLSCUI |
| CHEBI:87715 | CHEBI |
| CHEMBL1201772 | ChEMBL_ID |
| DB06209 | DRUGBANK_ID |
| CHEMBL1201773 | ChEMBL_ID |
| D000068799 | MESH_DESCRIPTOR_UI |
| 6918456 | PUBCHEM_CID |
| 7562 | IUPHAR_LIGAND_ID |
| 8503 | INN_ID |
| 34K66TBT99 | UNII |
| 613391 | RXNORM |
| 166281 | MMSL |
| 261080 | MMSL |
| 26287 | MMSL |
| 39620 | MMSL |
| d07409 | MMSL |
| 012994 | NDDF |
| 012995 | NDDF |
| 443129001 | SNOMEDCT_US |
| 443312008 | SNOMEDCT_US |
| 735166002 | SNOMEDCT_US |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Effient | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0002-5121 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
| Effient | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0002-5123 | TABLET, FILM COATED | 10 mg | ORAL | NDA | 32 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0378-5185 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 29 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0378-5185 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 29 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0378-5186 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 29 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0378-5186 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 29 sections |
| PRASUGREL | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0440-0604 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 29 sections |
| PRASUGREL | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0440-0605 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 29 sections |
| Effient | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0713-0881 | TABLET, COATED | 5 mg | ORAL | NDA | 33 sections |
| Effient | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0713-0882 | TABLET, COATED | 10 mg | ORAL | NDA | 33 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16729-272 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16729-272 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16729-272 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16729-273 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16729-273 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16729-273 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 43817-239 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 43817-240 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-4118 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 26 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-5169 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-5169 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-247 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-247 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-248 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-248 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-444 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 29 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-444 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 29 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-445 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 29 sections |
| Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-445 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 29 sections |
| Effient | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54868-6238 | TABLET, FILM COATED | 10 mg | ORAL | NDA | 28 sections |